Sanofi Expense From Equitysettled Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
Sanofi (SNYNF) reported Expense From Equitysettled Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of EUR 0 for the 6-month period ending 2020-06-30, per its 6-K filed 2020-07-29.
Discontinued › Operating Expenses
ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2020-07-29
| Period end | Expense From Equitysettled Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 6 month | Expense From Equitysettled Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|---|
| 2020-06-30 | 0.00 EUR 6-K · filed 2020-07-29 | |
| 2019-12-31 | 5.00M EUR 20-F · filed 2020-03-05 | |
| 2019-06-30 | 3.00M EUR 6-K · filed 2020-07-29 | |
| 2018-12-31 | 4.00M EUR 20-F · filed 2020-03-05 | |
| 2017-12-31 | 4.00M EUR 20-F · filed 2020-03-05 | |
| 2016-12-31 | 6.00M EUR 20-F · filed 2019-03-08 |